An overview of the c-MET signaling pathway - Shawna Leslie Organ, Ming-Sound Tsao, 2011
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
MET amplification causes EGFR-TKI resistance by activating... | Download Scientific Diagram
The role of MET in chemotherapy resistance | Oncogene
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling | Science
Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ on Twitter: "Great slides @ChristianRolfo on diagnostic challenges on MET amplification. #biomarker #lcsm #LungCancer https://t.co/zH1x2zrxYS" / Twitter
What Is MET? - MET Crusaders
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | Targeting MET Amplification as a New Oncogenic Driver
Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer - ESMO Open
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer | NEJM
MET gene analysis by next-generation sequencing & fluorescence | Oncotarget
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
EMT, MET amplification, and IGF-1R confer resistance to EGFR TKIs.... | Download Scientific Diagram
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer - Aguado - 2021 - Molecular Oncology - Wiley Online Library
Frontiers | I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: a case report
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
The multiple paths towards MET receptor addiction in cancer | Oncogene
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregula | OTT
Read in JCO:... - American Society of Clinical Oncology | Facebook
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | SpringerLink
Targeted Therapies Expanding for MET Dysregulation in NSCLC - ILCN.org (ILCN/WCLC)
MET and TP 53: How They Relate to ALK Lung Cancer — ALK POSITIVE
Targeting MET in Cancer: Obstacles and Potentials
Met signaling pathway and EGF receptor tyrosine kinase inhibitor... | Download Scientific Diagram
